Red Cedar Allergy Shots: The Eastern US Cupressaceae Anchor
Eastern red cedar allergy shots (SCIT) address America's most geographically widespread juniper — Juniperus virginiana spans 37 eastern and central states, peaking February–April when most patients think 'oak season' is responsible. Jun v 1 shares >80% sequence identity with mountain cedar's Jun a 1, so the rich Texas cedar-fever SCIT evidence base cross-applies directly. No red-cedar-specific US RCT exists, but the molecular rationale is among the strongest in tree-pollen immunology.
Eastern Red Cedar Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to eastern red cedar — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of eastern red cedar allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of eastern red cedar immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of eastern red cedar extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for eastern red cedar allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing eastern red cedar extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription eastern red cedar immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat eastern red cedar allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Eastern Red Cedar?
The biology, taxonomy, and clinical fingerprint of Eastern Red Cedar — the foundation of how SCIT targets it.
Juniperus virginiana male cones releasing pollen February–April. Eastern red cedar is the most widespread juniper in eastern North America, present in 37 states from the Atlantic coast to the Great Plains.
- Scientific name
- Juniperus virginiana
- Family
- CupressaceaeCypress family
- Type
- Early-spring tree pollen
- Native to
- Eastern and central North America; the most geographically widespread juniper species in eastern North America, spanning 37 states from Maine to Texas
- Allergen proteins
- Jun v 1 (major) — pectate lyase, ~43 kDa; >80% sequence identity with Jun a 1 (mountain cedar) — Midoro-Horiuti et al., JACI 1999;104:608–612Jun v 3 — thaumatin-like protein; minor allergen; limited cross-reactivity with peach, tomato, apple, kiwi in sensitized subsets
- Particle size
- ~22 μm
- Avoidance difficulty
- Nearly impossible
How Eastern Red Cedar Allergy Presents
Symptoms by body system — useful for distinguishing Eastern Red Cedar sensitivity from overlapping allergies and infections.
Respiratory
- Nasal congestion and rhinorrhea beginning in February in Virginia, Tennessee, and Missouri
- Sneezing episodes triggered by outdoor exposure during peak pollen release
- Asthma exacerbations in sensitized patients during the Feb–April Cupressaceae window
- Chronic cough and postnasal drip overlapping with early oak season
- Sinusitis from prolonged mucosal inflammation across the early spring season
Ocular
- Bilateral allergic conjunctivitis during February–April red cedar pollen release
- Periorbital swelling on high-count days across the 37-state range
- Persistent redness and watering extending into oak season overlap
Dermal
- Contact urticaria from handling cedar wood or foliage
- Generalized skin itching on high-pollen days in sensitized individuals
- Eczema flares in atopic patients during early spring cedar pollen season
Systemic
- Fatigue from sustained early-spring Cupressaceae exposure across the broad geographic range
- Sleep disruption from nocturnal nasal blockage during February–April peak
- Headache from sinus pressure during peak cedar count days
- Reduced productivity across the 10–12 week early spring window
Early spring allergy in February and March in patients from Tennessee to Virginia is most often eastern red cedar — the same pectate-lyase protein that drives Texas cedar fever in December, just shifted by two months and spread across 37 states. Most of these patients come in saying 'I think my oak allergy has gotten worse' — but oak barely pollinates until April.
When & Where Eastern Red Cedar Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: mid-February through mid-March in the Mid-Atlantic and Southeast; extending through April in the Northeast and Great Lakes· ~10–14 weeks; season shifts earlier with warming winters per Anderegg et al. PNAS 2021
US Exposure Map
8 high-intensity statesWhat Eastern Red Cedar Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Eastern red cedar's major allergen Jun v 1 shares >80% sequence identity with mountain cedar's Jun a 1 — placing the entire body of Texas cedar-fever SCIT literature within reach for red-cedar-allergic patients. The Cupressaceae pectate-lyase family extends cross-reactivity to Arizona cypress (Cup a 1, >75% identity), bald cypress, and Japanese cedar (Cry j 1).
Jun v 1 shares >80% sequence identity with Jun a 1 — mountain-cedar SCIT evidence cross-applies directly (Midoro-Horiuti 1999)
Cup a 1 / Jun v 1 same Cupressaceae pectate-lyase family; >75% identity (Midoro-Horiuti 1999)
Cross-reactivity by IgE inhibition with red cedar documented (Ramirez & Lockey, Ann Allergy Asthma Immunol 2012)
Jun v 3 thaumatin-like cross-reactivity; limited OAS in sensitized subset only
Cedar-Fruit Syndrome (Thaumatin-Like Cross-Reactivity)
A small subset of red-cedar-sensitized patients with IgE to Jun v 3 (thaumatin-like minor allergen) may experience mild oral allergy syndrome with certain fruits. This is much less common than the birch-apple OAS syndrome and typically causes only mild oral tingling.
Is SCIT Right for Your Eastern Red Cedar Allergy?
Answer five questions to assess whether eastern red cedar SCIT fits your early-spring allergy profile.
How severe are your early spring (February–March) allergy symptoms in the eastern US?
The Eastern Red Cedar SCIT Protocol
Eastern red cedar SCIT uses a non-standardized Jun v 1 extract. Build-up typically begins in August–September to reach maintenance before February cedar season. Because Jun v 1 and Jun a 1 are >80% identical, mountain-cedar extract may be used as the Cupressaceae anchor in regions where red-cedar-specific extract is unavailable.
Incremental dose escalation from the most dilute vial. Your allergist may prescribe juniper-mix if multiple Cupressaceae species are co-present, or single-species red cedar for patients in the eastern US. Traditionally each injection was followed by a 30-minute observation period in the clinic; with Curex, eligible patients self-administer the same escalation schedule at home, and the first dose plus every dose increase are supervised live over Zoom with a prescribed epinephrine auto-injector confirmed on hand.
Monthly maintenance injections sustain Jun v 1 tolerance. Cupressaceae family-wide cross-protection (via >80% Jun v 1 / Jun a 1 identity) builds during maintenance, addressing all pectate-lyase Cupressaceae species the patient encounters. With Curex these maintenance doses are self-administered at home, and a 30-minute self-observation continues throughout, with any dose change supervised live over Zoom.
After completing 3–5 years, your allergist evaluates lasting tolerance. Many patients sustain reduced early-spring cedar symptoms for years post-SCIT; some require extended courses.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Eastern Red Cedar SCIT
Red cedar SCIT is supported by mountain-cedar observational data and molecular cross-reactivity evidence rather than a species-specific US RCT. The >80% Jun v 1 / Jun a 1 identity makes the mountain-cedar evidence base directly applicable.
- Jun v 1 / Jun a 1 sequence identity (cross-protection basis)80%Midoro-Horiuti T et al., J Allergy Clin Immunol 1999;104:608–612 — >80% identity means mountain-cedar SCIT evidence directly applies to red cedar
- Mountain cedar SCIT observational benefit70%Goetz DW — observational series of mountain-cedar SCIT (Jun a 1 / Jun v 1 shared family); Ramirez DA & Lockey RF, Ann Allergy Asthma Immunol 2012
- Jun v 1 IgE reactivity in Cupressaceae-sensitized patients80%WHO/IUIS allergen.org — Jun v 1 named major allergen; IgE reactivity parallel to Jun a 1 in sensitized patients
No randomized controlled trial specific to eastern red cedar SCIT has been published as of 2025. The molecular basis for cross-applying mountain-cedar evidence (Goetz; Ramirez & Lockey 2012) is strong — >80% Jun v 1 / Jun a 1 sequence identity. The AAAAI/ACAAI Practice Parameter supports Cupressaceae SCIT for sensitized patients with refractory early-spring AR. The evidence gap — absence of a red-cedar-specific RCT — reflects the geographic concentration of Cupressaceae research in Texas, not a weakness in the protein-family rationale.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Eastern Red Cedar SCIT Side Effects
Eastern red cedar SCIT carries the standard inhalant immunotherapy side-effect profile — local reactions are expected during build-up; serious systemic reactions are rare under proper protocols.
Local reactions
4 documentedSystemic reactions
4 documentedRed cedar serum is sterile-compounded to USP <797>, and with Curex the first dose and every dose change are supervised live over Zoom with a prescribed epinephrine auto-injector confirmed on hand. A 30-minute post-injection self-observation captures the vast majority of systemic reactions (Greenhawt et al., Ann Allergy Asthma Immunol 2023).
SCIT vs Alternatives for Eastern Red Cedar
Eastern US patients with red cedar allergy have four options: SCIT (mountain-cedar evidence via Jun v 1 cross-reactivity) — now available as a weekly at-home injection with Curex — sublingual drops, avoidance, or daily antihistamines and nasal steroids.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Strongest for refractory early-spring cedar AR; mountain-cedar evidence cross-applies via >80% Jun v 1 / Jun a 1 identity | Emerging evidence; pectate-lyase drops show immunologic activity | Nearly impossible with 37-state geographic range in eastern US | Good for mild-moderate; may be insufficient during peak pollen counts |
| 5-yr cost | $3,500–$15,000 over 5 years | Varies by provider; sold as a general sublingual modality, not Curex's product | Low direct cost; high lifestyle burden | $300–$1,200/year for prescriptions |
| Duration | 3–5 years weekly then monthly | 3–5 years daily drops | Permanent lifestyle restriction | Lifelong seasonal use |
| Convenience | At-home weekly self-injection with Curex for ~6 months, then monthly; first dose and dose changes supervised live over Zoom | At-home; no clinic visits needed | HEPA filtration indoors helps; outdoor avoidance in Feb–March impractical | Convenient daily antihistamines and nasal steroids |
| Safety | Excellent; rare systemic reactions with observation | Lower systemic reaction risk than SCIT | No treatment risk; no disease modification | Well-established safety profile |
| Lasting effect | Years of lasting benefit after completing course | Duration of benefit still being studied | No lasting benefit; symptoms return every spring | No lasting benefit; symptoms return when medications stop |
SCITBest
SLIT
Avoidance
Medications
For eastern US patients with moderate-to-severe February–March cedar allergy who want lasting Cupressaceae family-wide cross-protection, SCIT is the established evidence-based option. Curex now delivers that SCIT as a weekly at-home injection at $129/month — the serum is sterile-compounded to USP <797>, your first dose and every dose change are supervised live over Zoom, and a prescribed epinephrine auto-injector is confirmed on hand — backed by the same Jun v 1 / Jun a 1 pectate-lyase cross-protection rationale (Midoro-Horiuti 1999).
What Eastern Red Cedar SCIT Actually Costs
Most major US insurers cover red cedar SCIT under standard allergy benefits when prescribed by a board-certified allergist in the eastern US. Red cedar is a well-documented regional aeroallergen across 37 states, and coverage is generally available. Out-of-pocket cost depends on your plan's deductible and co-insurance. Curex at-home IgE testing identifies specific eastern red cedar sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your eastern red cedar allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Eastern Red Cedar SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
No — eastern red cedar (Juniperus virginiana) and mountain cedar (Juniperus ashei) are closely related but distinct species. Mountain cedar is native to the Texas Hill Country and peaks December–February, producing the legendary 'cedar fever' with counts up to 32,000 grains/m³. Eastern red cedar spans 37 states from Maine to Texas and peaks February–April. Both species share the pectate-lyase major allergen (Jun v 1 and Jun a 1, respectively, with >80% sequence identity per Midoro-Horiuti 1999). The practical implication: if you have early-spring allergy in Virginia or Tennessee, it is likely red cedar — the same protein as Texas cedar fever, just occurring two months later and 1,000 miles east.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.